Skip to main content

Diabetes Device News

Diabetes Devices monitor and help to manage your blood sugar levels to try to stay within the target range, helping prevent complications of diabetes.

BGM    CGM     Injection Pens     Insulin Pumps      AID

Coming to US in Spring 2017: What it is, what it isn’t, and how to get it
Data from Bluetooth-enabled meter can now be shared with other health tracking apps.
Providers and patients will now see the same data - stay tuned for IBM Watson!
The Annual TCOYD/The diaTribe Foundation Forum Celebrates its 10 th Anniversary in New Orleans
$99 device makes pump and CGM data viewable to Android smartphone users. Plus, a first look at cool pattern recognition in the Sugar.IQ app with IBM Watson
Plus, Lilly invests $5 million! We talk to Dr. Ed Damiano to learn about the new Gen 3 version and upcoming studies.
Launching this June in Sweden, followed by Norway and Denmark. How does it compare to current CGM?
An 8-2 panel vote finds that benefits of using Dexcom’s G5 CGM for dosing insulin outweigh the risks; patient advocates provide compelling testimonies
Recruiting participants in Boston at the Joslin Diabetes Center
New improvements in the second-generation: better battery, app control, and more!
Matchstick-sized device implanted under the skin every 6-12 months. New data in over 4,000 people demonstrates it is safe for heart health. Could it launch by late 2017?
What does A1c miss and what can we do about it?
Tighter requirements for home meters. What does this mean for current and future blood glucose monitors?
Who is “closing the loop,” and how fast are they moving?
Includes insulin dose advisor software; plus, a new Novo Nordisk connected Echo insulin pen to debut in Europe later this year
Initiative encourages pump and CGM devices to use “open protocols” to enable the DIY community, innovation, and more options for automated insulin delivery
New Livongo Family Care Plan available without a prescription or insurance
iPhone users will be able to share insulin dose data between apps, paving way for ecosystem with smart pens and connected pumps
A basal insulin and GLP-1 agonist combo becomes available in the US and receives approval in Europe
Launch expected in 2018, possibly with no fingerstick calibration. Also, a 30% smaller transmitter and a new one-button inserter. Plus, what’s the latest on Medicare?

Pages